1,625 #patients were treated with interferon and ribavirin between 2000 and 2008, and were followed up through May 2014 to study the effects of non–#liver-related and non–#AIDS-related events among patients with #HCV/ #HIV coinfection. Results showed a significant reduction in the risk for #diabetes and chronic renal failure.